THXID™-BRAF
BioMerieux, Inc.
| Registration | FEI | Name | Status | Initial importer | Expiration year | Address |
|---|---|---|---|---|---|---|
| 1450405 | 1450405 | BIOMERIEUX, INC. | 1 | N | 2026-01-01 | 1105 N Main St LOMBARD IL US 60148 |
| 1950204 | 1950204 | BIOMERIEUX, INC. | 1 | Y | 2026-01-01 | 595 ANGLUM RD. HAZELWOOD MO US 63042 |
| 8020790 | 1000611339 | BIOMERIEUX SA | 1 | N | 2026-01-01 | CHEMIN DE L ORME MARCY L ETOILE Rhone FR 69280 |
| 9615778 | 1000351505 | BioMerieux SA | 1 | N | 2026-01-01 | PARC TECHNOLOGIQUE DELTA SUD VERNIOLLE Ariege FR 09340 |
| 3002769706 | 3002769706 | BIOMERIEUX, INC. | 1 | N | 2026-01-01 | 100 RODOLPHE ST DURHAM NC US 27712 |
| 3025775667 | 3025775667 | BIOMERIEUX, INC. | 1 | N | 2026-01-01 | 1201 S 4800 W Salt Lake City UT US 84104 |
| 3031977134 | 3031977134 | bioMerieux, Inc. | 1 | N | 2026-01-01 | 3015 Carrington Mill Blvd Morrisville NC US 27560 |
| Registration key | Listing key | Premarket submission | Device | Product code | Decision date |
|---|---|---|---|---|---|
| 9759 | 1564096010 | N50510 | VITEK SYSTEMS GENERAL SUSCEPTIBILITY CARD | LTW | 1978-03-02 |
| 330867 | 1564096010 | N50510 | VITEK SYSTEMS GENERAL SUSCEPTIBILITY CARD | LTW | 1978-03-02 |
| 342170 | 1564096010 | N50510 | VITEK SYSTEMS GENERAL SUSCEPTIBILITY CARD | LTW | 1978-03-02 |
| 9764 | 1537244710 | K993319 | VIDAS TOXO IGG II (TXG) ASSAY MODEL 30 210 | LGD | 2000-05-22 |
| 148374 | 1525569376 | K982311 | BARTELS CINAKIT CMV ANTIGENEMIA | GQH | 1998-12-14 |
| 9759 | 1719697936 | K981736 | BACT/ALERT 3D MICROBIAL DETECTION SYSTEM | MDB | 1998-07-24 |
| 330867 | 1719697936 | K981736 | BACT/ALERT 3D MICROBIAL DETECTION SYSTEM | MDB | 1998-07-24 |
| 9764 | 1770102084 | K965084 | VIDAS PROESTERONE (PRG) (30 409) | JLS | 1997-01-09 |
| 9759 | 1368307575 | K962609 | GRAM NEGATIVE IDENTIFICATION PLUS CARD | LRH | 1996-08-30 |
| 9764 | 1745557297 | K955647 | VIDAS ESTRADIOL II (E2II) ASSAY | CHP | 1996-02-06 |
| 9764 | 1379022031 | K943811 | ENZYME-LINKED FLUORESCENT IMMUNOASSAY | CFT | 1994-11-02 |
| 9756 | 1067684892 | K933939 | BACT/ALERT BLOOD COLLECTION ADAPTER CAP AND INSERT | GIM | 1994-02-07 |
| 9764 | 1450844303 | K933549 | VIDAS CMV IGM ASSAY | LKQ | 1994-08-02 |
| 9764 | 1611155107 | K931031 | VIDAS CORTISOL (CORT) ASSAY & SERUM FREE DILUTENT | JFT | 1993-07-27 |
| 9764 | 1423114172 | K926393 | VIDAS THYROXINE (T4) ASSAY (T4) | KLI | 1993-05-13 |
| 9764 | 1269410502 | K923903 | VITEK IMMUNODIAGNOSTIC ASSAY SYSTEM MUMPS IGG ASSA | LJY | 1993-08-09 |
| 9764 | 1002959347 | K923166 | VIDAS TOXOPLASMA GONDII IGM ASSSAY | LGD | 1993-02-25 |
| 9764 | 1281385715 | K923122 | VITEK IMMUNODIAGNOSTIC ASSAY SYSTEM | LFY | 1992-10-26 |
| 9764 | 1825876568 | K921816 | VITEK IMMUN ASSAY SYS(VIDAS) THYROI STIM HOR ASSAY | JLW | 1992-06-18 |
| 9764 | 1231628086 | K921746 | VITEK IMMUNODIAGNOSTIC ASSAY SYSTEM | CGJ | 1992-06-16 |
| 9764 | 1905594449 | K921302 | VITEK IMMUNODIAGNOSTIC ASSAY SYSTEM | JHI | 1992-07-28 |
| 9764 | 1499689746 | K921176 | VITEK IMMUNODIAGNOSTIC ASSAY SYSTEM | CEP | 1992-04-08 |
| 9764 | 1411609845 | K920661 | VIDAS CMV IGG ASSAY | LFZ | 1993-02-12 |
| 9759 | 1825208256 | K910666 | VITEK ANAEROBE IDENTIFICATION CARD, MODIFICATION | JSP | 1991-04-03 |
| 9759 | 2035124959 | K910304 | RAPID CORYNE SYST/IDENTIF OF CORYNEFORM BACTERIA | LQL | 1991-07-26 |
| 9759 | 1668132539 | K903505 | BACT/ALERT (TM) | MDB | 1991-03-12 |
| 330867 | 1668132539 | K903505 | BACT/ALERT (TM) | MDB | 1991-03-12 |
| 9759 | 1332586277 | K881925 | VITEK YEAST BIOCHEMICAL CARD | JXB | 1988-06-16 |
| 9759 | 1593912752 | K260282 | VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance | LON | 2026-04-15 |
| 9759 | 1673548259 | K260281 | VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL) | LON | 2026-03-26 |
| 9759 | 1817280878 | K251579 | VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL) | LON | 2025-08-21 |
| 9764 | 1799160986 | K240279 | VIDAS TBI (GFAP, UCH-L1) | QAT | 2024-05-01 |
| 9759 | 1991303695 | K234012 | VITEK COMPACT PRO | LON | 2025-03-14 |
| 9759 | 1428133906 | K234000 | VITEK 2 AST-Gram Positive Lefamulin (<=0.03 - >=4 µg/mL) | LON | 2024-03-11 |
| 330867 | 1428133906 | K234000 | VITEK 2 AST-Gram Positive Lefamulin (<=0.03 - >=4 µg/mL) | LON | 2024-03-11 |
| 9759 | 1231259373 | K232967 | VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL) | NGZ | 2024-06-12 |
| 330867 | 1231259373 | K232967 | VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL) | NGZ | 2024-06-12 |
| 9759 | 1398877114 | K232963 | VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL) | NGZ | 2024-06-07 |
| 330867 | 1398877114 | K232963 | VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL) | NGZ | 2024-06-07 |
| 9759 | 2065733366 | K232201 | VITEK 2 AST-Streptococcus Penicillin (<=0.06 - =>8 µg/mL), VITEK 2 Streptococcus Penicillin (<=0.06 - >=8 µg/mL), VITEK 2 Streptococcus Penicillin | LON | 2023-10-23 |
| 330867 | 2065733366 | K232201 | VITEK 2 AST-Streptococcus Penicillin (<=0.06 - =>8 µg/mL), VITEK 2 Streptococcus Penicillin (<=0.06 - >=8 µg/mL), VITEK 2 Streptococcus Penicillin | LON | 2023-10-23 |
| 9759 | 1745152233 | K230864 | VITEK 2 AST-Gram Positive Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin | LON | 2023-07-05 |
| 330867 | 1745152233 | K230864 | VITEK 2 AST-Gram Positive Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin | LON | 2023-07-05 |
| 9759 | 1047179699 | K230675 | VITEK REVEAL GN AST Assay and VITEK REVEAL AST System | SAN | 2024-06-20 |
| 9759 | 1627179255 | K223481 | VITEK® 2 Streptococcus Tetracycline (<=0.25 - >=16 µg/mL) | LON | 2023-02-03 |
| 330867 | 1627179255 | K223481 | VITEK® 2 Streptococcus Tetracycline (<=0.25 - >=16 µg/mL) | LON | 2023-02-03 |
| 9759 | 1553255155 | K223478 | VITEK® 2 AST-Gram Negative Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin | LON | 2023-02-16 |
| 330867 | 1553255155 | K223478 | VITEK® 2 AST-Gram Negative Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin | LON | 2023-02-16 |
| 9759 | 1381519264 | K222430 | VITEK 2 AST-Gram Negative Fosfomycin (<=4 - >=256 µg/mL), VITEK 2 AST-GN Fosfomycin (<=4 - >=256 µg/mL), VITEK 2 AST-GN Fosfomycin | LON | 2023-03-09 |
| 330867 | 1381519264 | K222430 | VITEK 2 AST-Gram Negative Fosfomycin (<=4 - >=256 µg/mL), VITEK 2 AST-GN Fosfomycin (<=4 - >=256 µg/mL), VITEK 2 AST-GN Fosfomycin | LON | 2023-03-09 |
| 9759 | 1474667258 | K222378 | VITEK 2 AST-Gram Negative Levofloxacin (</=0.125 ->/=8 ug/mL) | LON | 2023-06-26 |
| 330867 | 1474667258 | K222378 | VITEK 2 AST-Gram Negative Levofloxacin (</=0.125 ->/=8 ug/mL) | LON | 2023-06-26 |
| 9759 | 1407256092 | K222073 | VITEK 2 AST-Gram Negative Cefazolin (<=1 - >=32 ug/mL) | LON | 2023-02-09 |
| 330867 | 1407256092 | K222073 | VITEK 2 AST-Gram Negative Cefazolin (<=1 - >=32 ug/mL) | LON | 2023-02-09 |
| 9759 | 1206437726 | K220805 | VITEK 2 AST-Gram Positive Cefoxitin Screen | LON | 2022-10-13 |
| 330867 | 1206437726 | K220805 | VITEK 2 AST-Gram Positive Cefoxitin Screen | LON | 2022-10-13 |
| 9759 | 1605615652 | K220803 | VITEK 2 AST-Gram Positive Moxifloxacin (=0.25 - =8 µg/ml), VITEK 2 AST-GP Moxifloxacin (=0.25 - =8 µg/mL), VITEK 2 AST-GP Moxifloxacin | LON | 2023-01-27 |
| 330867 | 1605615652 | K220803 | VITEK 2 AST-Gram Positive Moxifloxacin (=0.25 - =8 µg/ml), VITEK 2 AST-GP Moxifloxacin (=0.25 - =8 µg/mL), VITEK 2 AST-GP Moxifloxacin | LON | 2023-01-27 |
| 9759 | 1817842505 | K214023 | VITEK 2 AST-Gram Negative Ciprofloxacin (?0.06 - ?4 µg/mL) | LON | 2022-04-14 |
| 330867 | 1817842505 | K214023 | VITEK 2 AST-Gram Negative Ciprofloxacin (?0.06 - ?4 µg/mL) | LON | 2022-04-14 |
| 9759 | 1159861971 | K213931 | VITEK 2 AST-Gram Negative Omadacycline (<=0.25 - >=16 µg/mL) | LON | 2022-06-03 |
| 330867 | 1159861971 | K213931 | VITEK 2 AST-Gram Negative Omadacycline (<=0.25 - >=16 µg/mL) | LON | 2022-06-03 |
| 9759 | 1624805318 | K213899 | VITEK 2 AST-Yeast Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin | LON | 2022-07-12 |
| 330867 | 1624805318 | K213899 | VITEK 2 AST-Yeast Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin | LON | 2022-07-12 |
| 9759 | 1402319659 | K213241 | VITEK 2 AST-Yeast Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole | LON | 2022-02-25 |
| 330867 | 1402319659 | K213241 | VITEK 2 AST-Yeast Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole | LON | 2022-02-25 |
| 9759 | 2004365094 | K212849 | VITEK 2 AST-Gram Positive Linezolid (<=0.5 – >=8 µg/mL) | LON | 2022-02-04 |
| 330867 | 2004365094 | K212849 | VITEK 2 AST-Gram Positive Linezolid (<=0.5 – >=8 µg/mL) | LON | 2022-02-04 |
| 9759 | 1595386780 | K212243 | VITEK 2 AST- Gram Positive Telavancin (<=0.015 - >=1 µg/mL) | LON | 2022-08-08 |
| 330867 | 1595386780 | K212243 | VITEK 2 AST- Gram Positive Telavancin (<=0.015 - >=1 µg/mL) | LON | 2022-08-08 |
| 9759 | 1187639540 | K211630 | VITEK 2 AST-Gram Negative Piperacillin / Tazobactam (<=4 - =>128 µg/mL) | LON | 2021-08-30 |
| 330867 | 1187639540 | K211630 | VITEK 2 AST-Gram Negative Piperacillin / Tazobactam (<=4 - =>128 µg/mL) | LON | 2021-08-30 |
| 9759 | 1455172546 | K211136 | VITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML) | LON | 2021-06-14 |
| 330867 | 1455172546 | K211136 | VITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML) | LON | 2021-06-14 |
| 9764 | 1533054064 | K210793 | VIDAS NEPHROCHECK | PIG | 2022-07-08 |
| 9759 | 1118608189 | K210287 | VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL) | LON | 2021-10-28 |
| 330867 | 1118608189 | K210287 | VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL) | LON | 2021-10-28 |
| 9759 | 2016796042 | K202396 | VITEK 2 AST-Gram Positive Fosfomycin (<=8 - >=256 ug/mL) | LON | 2021-09-14 |
| 330867 | 2016796042 | K202396 | VITEK 2 AST-Gram Positive Fosfomycin (<=8 - >=256 ug/mL) | LON | 2021-09-14 |
| 9759 | 1812779869 | K201675 | VITEK 2 AST-Gram Negative Meropenem (<= 0.25 - >=16 µg/mL) | LON | 2021-07-09 |
| 330867 | 1812779869 | K201675 | VITEK 2 AST-Gram Negative Meropenem (<= 0.25 - >=16 µg/mL) | LON | 2021-07-09 |
| 9759 | 1132359229 | K200590 | VITEK 2 AST-Gram Positive Delafloxacin (<=0.015 - >=1 µg/mL) | LON | 2020-04-28 |
| 330867 | 1132359229 | K200590 | VITEK 2 AST-Gram Positive Delafloxacin (<=0.015 - >=1 µg/mL) | LON | 2020-04-28 |
| 9759 | 1951517469 | K193572 | VITEK 2 AST-Gram Negative Imipenem/Relebactam (<=0.25/4 - >=16/4 µg/mL) | LON | 2020-03-13 |
| 330867 | 1951517469 | K193572 | VITEK 2 AST-Gram Negative Imipenem/Relebactam (<=0.25/4 - >=16/4 µg/mL) | LON | 2020-03-13 |
| 9759 | 1453194829 | K193567 | VITEK 2 AST- Gram Negative Polymyxin B (<=0.25 – >=16 ug/mL) | LON | 2020-02-14 |
| 330867 | 1453194829 | K193567 | VITEK 2 AST- Gram Negative Polymyxin B (<=0.25 – >=16 ug/mL) | LON | 2020-02-14 |
| 9759 | 1320590281 | K193299 | VITEK 2 AST-Gram Negative Ceftazidime (=<0.5 - =>32 µg/mL) | LON | 2020-09-28 |
| 330867 | 1320590281 | K193299 | VITEK 2 AST-Gram Negative Ceftazidime (=<0.5 - =>32 µg/mL) | LON | 2020-09-28 |
| 9759 | 1379065502 | K192110 | Vitek Densichek | LON | 2019-10-31 |
| 330867 | 1379065502 | K192110 | Vitek Densichek | LON | 2019-10-31 |
| 9759 | 1004959614 | K191766 | VITEK 2 AST-Gram Negative Eravacycline (<=0.12 - >=4µg/mL) | LON | 2019-08-05 |
| 330867 | 1004959614 | K191766 | VITEK 2 AST-Gram Negative Eravacycline (<=0.12 - >=4µg/mL) | LON | 2019-08-05 |
| 9759 | 2026414414 | K190616 | VITEK 2 AST-Gram Positive Dalbavancin (<= 0.015 - >= 1 µg/mL) | LON | 2019-06-06 |
| 330867 | 2026414414 | K190616 | VITEK 2 AST-Gram Positive Dalbavancin (<= 0.015 - >= 1 µg/mL) | LON | 2019-06-06 |
| 9756 | 2035384580 | K190405 | BACT/ALERT MP Reagent System | MDB | 2019-05-15 |
| 330867 | 2035384580 | K190405 | BACT/ALERT MP Reagent System | MDB | 2019-05-15 |
| 9759 | 1708414493 | K183551 | VITEK 2 AST-Gram Negative Minocycline (<= 0.5 - >= 32 ug/mL) | LON | 2019-03-07 |
| 330867 | 1708414493 | K183551 | VITEK 2 AST-Gram Negative Minocycline (<= 0.5 - >= 32 ug/mL) | LON | 2019-03-07 |
| 9759 | 2070488037 | K183524 | VITEK2 AST-Gram Negative Delafloxacin (<=0.06->=4 ug/mL) | LON | 2019-03-12 |
| 330867 | 2070488037 | K183524 | VITEK2 AST-Gram Negative Delafloxacin (<=0.06->=4 ug/mL) | LON | 2019-03-12 |
| 9759 | 1669506464 | K183415 | VITEK 2 AST-Gram Negative Imipenem (</=0.25->= 16 ug/mL) | LON | 2019-02-20 |
| 330867 | 1669506464 | K183415 | VITEK 2 AST-Gram Negative Imipenem (</=0.25->= 16 ug/mL) | LON | 2019-02-20 |
| 9759 | 1924967931 | K183360 | VITEK 2 AST-Gram Negative Meropenem/Vaborbactam (<=0.5/8 – >=64/8 µg/mL) | LON | 2019-02-26 |
| 330867 | 1924967931 | K183360 | VITEK 2 AST-Gram Negative Meropenem/Vaborbactam (<=0.5/8 – >=64/8 µg/mL) | LON | 2019-02-26 |
| 9756 | 1664950732 | K183166 | BacT/ALERT FA Plus; BacT/ALERT PF Plus | MDB | 2019-02-11 |
| 330867 | 1664950732 | K183166 | BacT/ALERT FA Plus; BacT/ALERT PF Plus | MDB | 2019-02-11 |
| 9759 | 1867165198 | K181766 | VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance | LON | 2018-12-10 |
| 330867 | 1867165198 | K181766 | VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance | LON | 2018-12-10 |
| 9759 | 1378472382 | K172944 | VITEK 2 AST-GN Ceftazidime/Avibactam <=0.12 – >=16 µg/mL | LON | 2017-12-19 |
| 330867 | 1378472382 | K172944 | VITEK 2 AST-GN Ceftazidime/Avibactam <=0.12 – >=16 µg/mL | LON | 2017-12-19 |
| 9759 | 1029844055 | K172731 | VITEK 2 AST-GN Amikacin (<=1 ->=64 ug/mL) | LON | 2017-12-08 |
| 330867 | 1029844055 | K172731 | VITEK 2 AST-GN Amikacin (<=1 ->=64 ug/mL) | LON | 2017-12-08 |
| 9759 | 1310520682 | K163563 | VITEK 2 AST-GN Gentamicin (<=1 – >=16 µg/mL) | LON | 2017-03-13 |
| 330867 | 1310520682 | K163563 | VITEK 2 AST-GN Gentamicin (<=1 – >=16 µg/mL) | LON | 2017-03-13 |
| 9759 | 1456632838 | K163083 | VITEK 2 AST-GN Tobramycin (</=1->/= 16 ug/mL); VITEK 2 AST-Gram Negative Tobramycin (</=1->/=16 ug/mL) | LON | 2017-02-01 |
| 330867 | 1456632838 | K163083 | VITEK 2 AST-GN Tobramycin (</=1->/= 16 ug/mL); VITEK 2 AST-Gram Negative Tobramycin (</=1->/=16 ug/mL) | LON | 2017-02-01 |
| 9759 | 1883272043 | K163006 | VITEK 2 AST-GN Tigecycline (<0.5->8 ug/mL) | LON | 2017-01-24 |
| 330867 | 1883272043 | K163006 | VITEK 2 AST-GN Tigecycline (<0.5->8 ug/mL) | LON | 2017-01-24 |
| 9764 | 2034395095 | K162827 | VIDAS B.R.A.H.M.S. PCT (PCT) | PRI | 2017-02-23 |
| Product code | Registration listing records | Latest decision |
|---|---|---|
| LON | 216 | 2026-04-15 |
| MDB | 27 | 2019-05-15 |
| NGZ | 11 | 2024-06-12 |
| LGD | 3 | 2011-05-18 |
| LTW | 3 | 1978-03-02 |
| LSR | 2 | 2013-06-04 |
| SAN | 1 | 2024-06-20 |
| QAT | 1 | 2024-05-01 |
| PIG | 1 | 2022-07-08 |
| PRI | 1 | 2017-02-23 |
| PMT | 1 | 2016-06-28 |
| MCB | 1 | 2013-10-09 |
| DAP | 1 | 2012-07-31 |
| LFX | 1 | 2008-12-23 |
| LLH | 1 | 2008-06-11 |
| NTM | 1 | 2007-10-11 |
| LYR | 1 | 2000-10-04 |
| GQH | 1 | 1998-12-14 |
| JLS | 1 | 1997-01-09 |
| LRH | 1 | 1996-08-30 |
| CHP | 1 | 1996-02-06 |
| CFT | 1 | 1994-11-02 |
| LKQ | 1 | 1994-08-02 |
| GIM | 1 | 1994-02-07 |
| LJY | 1 | 1993-08-09 |
| JFT | 1 | 1993-07-27 |
| KLI | 1 | 1993-05-13 |
| LFZ | 1 | 1993-02-12 |
| LFY | 1 | 1992-10-26 |
| JHI | 1 | 1992-07-28 |
| JLW | 1 | 1992-06-18 |
| CGJ | 1 | 1992-06-16 |
| CEP | 1 | 1992-04-08 |
| LQL | 1 | 1991-07-26 |
| JSP | 1 | 1991-04-03 |
| JXB | 1 | 1988-06-16 |
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BIOMERIEUX VITEK, INC.
BIOMERIEUX VITEK, INC.
BIOMERIEUX VITEK, INC.
BIOMERIEUX VITEK, INC.
BIOMERIEUX VITEK, INC.
BIOMERIEUX VITEK, INC.
BIOMERIEUX VITEK, INC.
BIOMERIEUX VITEK, INC.
BIOMERIEUX VITEK, INC.
BIOMERIEUX VITEK, INC.
BIOMERIEUX VITEK, INC.
BIOMERIEUX VITEK, INC.
Biomérieux
Biomerieux S.A.
bioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
Biomérieux
bioMerieux, Inc.
bioMerieux, Inc.
Biomerieux Sa, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
BioMerieux, Inc
bioMerieux, Inc.
bioMerieux, Inc.
BioMérieux SA
BioMerieux, Inc.
BioMerieux, Inc
BioMerieux, Inc.
BioMerieux, Inc.
BioMérieux, Inc
BioMerieux SA
BioMerieux, Inc
bioMerieux, Inc.
bioMerieux, Inc.
BioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
BioMerieux, Inc.
BioMérieux S.A.
bioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux SA
BioMerieux, Inc
BioMerieux SA
2019-08-30
2016-08-31
2019-04-30
2022-04-15
2026-01-19
2025-05-15
2020-06-26
2020-06-26
2016-12-12
2019-06-12
2016-11-30
2025-05-15
2022-04-11
2019-07-19
2019-07-19
2017-05-12
2019-11-19
2016-08-12
2016-08-12
2016-08-12
2016-08-12
2016-11-18
2016-11-18
2016-11-18
2016-11-18
2016-11-18
2016-11-18
2020-05-19
2016-11-18
2016-11-18
2019-01-28
2020-04-10
2020-05-19
2020-05-19
2020-05-19
2022-04-05
2020-05-19
2020-05-19
2020-05-19
2020-05-19